BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10225429)

  • 1. Cannabinoid receptor CB1 activates the Na+/H+ exchanger NHE-1 isoform via Gi-mediated mitogen activated protein kinase signaling transduction pathways.
    Bouaboula M; Bianchini L; McKenzie FR; Pouyssegur J; Casellas P
    FEBS Lett; 1999 Apr; 449(1):61-5. PubMed ID: 10225429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions.
    Bouaboula M; Perrachon S; Milligan L; Canat X; Rinaldi-Carmona M; Portier M; Barth F; Calandra B; Pecceu F; Lupker J; Maffrand JP; Le Fur G; Casellas P
    J Biol Chem; 1997 Aug; 272(35):22330-9. PubMed ID: 9268384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1.
    Bouaboula M; Poinot-Chazel C; Bourrié B; Canat X; Calandra B; Rinaldi-Carmona M; Le Fur G; Casellas P
    Biochem J; 1995 Dec; 312 ( Pt 2)(Pt 2):637-41. PubMed ID: 8526880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of CB1 cannabinoid receptor functions after a long-term exposure to agonist or inverse agonist in the Chinese hamster ovary cell expression system.
    Rinaldi-Carmona M; Le Duigou A; Oustric D; Barth F; Bouaboula M; Carayon P; Casellas P; Le Fur G
    J Pharmacol Exp Ther; 1998 Dec; 287(3):1038-47. PubMed ID: 9864290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.
    Derocq JM; Bouaboula M; Marchand J; Rinaldi-Carmona M; Ségui M; Casellas P
    FEBS Lett; 1998 Apr; 425(3):419-25. PubMed ID: 9563506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor.
    Calandra B; Portier M; Kernéis A; Delpech M; Carillon C; Le Fur G; Ferrara P; Shire D
    Eur J Pharmacol; 1999 Jun; 374(3):445-55. PubMed ID: 10422789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression.
    Bouaboula M; Poinot-Chazel C; Marchand J; Canat X; Bourrié B; Rinaldi-Carmona M; Calandra B; Le Fur G; Casellas P
    Eur J Biochem; 1996 May; 237(3):704-11. PubMed ID: 8647116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gα
    Porcu A; Melis M; Turecek R; Ullrich C; Mocci I; Bettler B; Gessa GL; Castelli MP
    Neuropharmacology; 2018 May; 133():107-120. PubMed ID: 29407764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osmotic stimulation of the Na+/H+ exchanger NHE1: relationship to the activation of three MAPK pathways.
    Gillis D; Shrode LD; Krump E; Howard CM; Rubie EA; Tibbles LA; Woodgett J; Grinstein S
    J Membr Biol; 2001 Jun; 181(3):205-14. PubMed ID: 11420607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.
    Rinaldi-Carmona M; Barth F; Millan J; Derocq JM; Casellas P; Congy C; Oustric D; Sarran M; Bouaboula M; Calandra B; Portier M; Shire D; Brelière JC; Le Fur GL
    J Pharmacol Exp Ther; 1998 Feb; 284(2):644-50. PubMed ID: 9454810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of two cloned human CB1 cannabinoid receptor isoforms.
    Rinaldi-Carmona M; Calandra B; Shire D; Bouaboula M; Oustric D; Barth F; Casellas P; Ferrara P; Le Fur G
    J Pharmacol Exp Ther; 1996 Aug; 278(2):871-8. PubMed ID: 8768742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the carboxyl terminus of the third intracellular loop of the cannabinoid CB1 receptor in constitutive activation of Gs.
    Abadji V; Lucas-Lenard JM; Chin C; Kendall DA
    J Neurochem; 1999 May; 72(5):2032-8. PubMed ID: 10217281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gi protein modulation induced by a selective inverse agonist for the peripheral cannabinoid receptor CB2: implication for intracellular signalization cross-regulation.
    Bouaboula M; Desnoyer N; Carayon P; Combes T; Casellas P
    Mol Pharmacol; 1999 Mar; 55(3):473-80. PubMed ID: 10051530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric modulator ORG27569 induces CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization, and Gi protein-independent ERK1/2 kinase activation.
    Ahn KH; Mahmoud MM; Kendall DA
    J Biol Chem; 2012 Apr; 287(15):12070-82. PubMed ID: 22343625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function.
    Eldeeb K; Leone-Kabler S; Howlett AC
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):311-22. PubMed ID: 27089415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528.
    Shire D; Calandra B; Bouaboula M; Barth F; Rinaldi-Carmona M; Casellas P; Ferrara P
    Life Sci; 1999; 65(6-7):627-35. PubMed ID: 10462063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two G protein-coupled receptors activate Na+/H+ exchanger isoform 1 in Chinese hamster lung fibroblasts through an ERK-dependent pathway.
    Wallert MA; Thronson HL; Korpi NL; Olmschenk SM; McCoy AC; Funfar MR; Provost JJ
    Cell Signal; 2005 Feb; 17(2):231-42. PubMed ID: 15494214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrity of extracellular loop 1 of the human cannabinoid receptor 1 is critical for high-affinity binding of the ligand CP 55,940 but not SR 141716A.
    Murphy JW; Kendall DA
    Biochem Pharmacol; 2003 May; 65(10):1623-31. PubMed ID: 12754098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors.
    MacLennan SJ; Reynen PH; Kwan J; Bonhaus DW
    Br J Pharmacol; 1998 Jun; 124(4):619-22. PubMed ID: 9690851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of CB1 receptors on rat neuronal cell cultures: binding and functional studies using the selective receptor antagonist SR 141716A.
    Jung M; Calassi R; Rinaldi-Carmona M; Chardenot P; Le Fur G; Soubrié P; Oury-Donat F
    J Neurochem; 1997 Jan; 68(1):402-9. PubMed ID: 8978752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.